Insider · CIK 0001807484

Bunker Kevin D.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001807484

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-12-20	ZNTLZentalis Pharmaceuticals, Inc.G Gift	Chief Scientific Officer	GGift	−24.2K sh	—	—	834,931
2023-10-04	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−5,085 sh	$19.43	−$98.8K	860,072
2023-10-04	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−983 sh	$19.91	−$19.6K	859,089
2023-05-26	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−80K sh	$30.02	−$2.4M	15,000
2023-02-14	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−6,500 sh	$19.98	−$130K	865,157
2023-02-13	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,807 sh	$20.42	−$77.8K	871,657
2023-02-01	ZNTLZentalis Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+91.4K sh	—	—	875,464
2023-02-01	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+133K sh	—	—	132,646
2022-11-09	ZNTLZentalis Pharmaceuticals, Inc.G Gift	Chief Scientific Officer	GGift	−30K sh	—	—	784,110
2022-10-03	ZNTLZentalis Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+50K sh	—	—	814,110
2022-10-03	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+50K sh	—	—	50,000
2022-08-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$30.00	−$150K	95,000
2022-07-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−5,000 sh	$30.00	−$150K	100,000
2022-07-14	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,290 sh	$30.01	−$98.7K	105,000
2022-07-13	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,710 sh	$30.02	−$51.3K	108,290
2022-07-05	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−25K sh	$30.07	−$752K	110,000
2022-04-11	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−4,600 sh	$30.37	−$140K	135,400
2022-04-11	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−300 sh	$32.40	−$9,720	135,100
2022-04-11	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−100 sh	$33.16	−$3,316	135,000
2022-03-21	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−5,556 sh	$48.72	−$271K	144,444
2022-03-21	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−4,444 sh	$49.50	−$220K	140,000
2022-03-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−4,000 sh	$46.23	−$185K	156,000
2022-03-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−4,301 sh	$47.18	−$203K	151,699
2022-03-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,699 sh	$47.99	−$81.5K	150,000
2022-02-22	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−800 sh	$47.08	−$37.7K	169,200
2022-02-22	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−6,343 sh	$48.95	−$310K	162,857
2022-02-22	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,451 sh	$49.92	−$122K	160,406
2022-02-22	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−406 sh	$50.39	−$20.5K	160,000
2022-02-14	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,622 sh	$50.16	−$81.4K	767,176
2022-02-14	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−203 sh	$50.75	−$10.3K	766,973
2022-02-14	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,863 sh	$50.29	−$144K	764,110
2022-02-10	ZNTLZentalis Pharmaceuticals, Inc.A Award	Chief Scientific Officer	AAward	+22.5K sh	—	—	768,798
2022-02-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,366 sh	$52.15	−$123K	177,634
2022-02-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,074 sh	$53.19	−$164K	174,560
2022-02-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,321 sh	$54.20	−$180K	171,239
2022-02-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,239 sh	$54.96	−$68.1K	170,000
2022-02-10	ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+52.7K sh	—	—	52,745
2022-01-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,753 sh	$59.17	−$163K	187,247
2022-01-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−6,537 sh	$60.20	−$394K	180,710
2022-01-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−710 sh	$61.29	−$43.5K	180,000
2022-01-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,146 sh	$67.24	−$212K	196,854
2022-01-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,807 sh	$68.05	−$191K	194,047
2022-01-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,835 sh	$69.03	−$127K	192,212
2022-01-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,212 sh	$70.02	−$155K	190,000
2021-12-30	ZNTLZentalis Pharmaceuticals, Inc.G Gift	Chief Scientific Officer	GGift	−8,750 sh	—	—	746,317
2021-12-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,161 sh	$77.45	−$167K	207,839
2021-12-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−1,879 sh	$78.52	−$148K	205,960
2021-12-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−3,889 sh	$79.78	−$310K	202,071
2021-12-20	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−2,071 sh	$80.76	−$167K	200,000
2021-12-10	ZNTLZentalis Pharmaceuticals, Inc.S Sale	Chief Scientific Officer	SSale	−434 sh	$70.29	−$30.5K	219,566

Recent filings

Accepted (ET)
Dec 214
Bunker Kevin D.0001725160-23-000203
SEC(opens sec.gov)
Oct 64
Bunker Kevin D.0001725160-23-000180
SEC(opens sec.gov)
May 314
Bunker Kevin D.0001725160-23-000124
SEC(opens sec.gov)
Feb 144
Bunker Kevin D.0001725160-23-000031
SEC(opens sec.gov)
Feb 14
Bunker Kevin D.0001725160-23-000020
SEC(opens sec.gov)
Oct 34
Bunker Kevin D.0001725160-22-000179
SEC(opens sec.gov)
Aug 124
Bunker Kevin D.0001725160-22-000159
SEC(opens sec.gov)
Jul 204
Bunker Kevin D.0001725160-22-000135
SEC(opens sec.gov)
Jul 144
Bunker Kevin D.0001725160-22-000133
SEC(opens sec.gov)
Jul 64
Bunker Kevin D.0001725160-22-000131
SEC(opens sec.gov)
Apr 134
Bunker Kevin D.0001725160-22-000078
SEC(opens sec.gov)
Mar 214
Bunker Kevin D.0001725160-22-000063
SEC(opens sec.gov)

Companies

Zentalis Pharmaceuticals, Inc.Chief Scientific OfficerZNTL

Address

C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201

NEW YORK, NY, 10018